CVS’ other goals include the introduction of new products
and services as well as the creation of a strong technology infrastructure. The
company expects to generate approx. $300-350 million of synergies from the
Aetna integration in 2019 and approx. $800 million in 2020.
CVS reaffirmed its guidance for full-year 2019. The company expects consolidated revenues to come in the range of $251.2 billion to $254.4 billion. On a GAAP basis, operating income is expected to be $11.8 billion to $12 billion and on an adjusted basis, operating income is expected to be $15 billion to $15.2 billion.
GAAP diluted EPS is projected to be $4.90 to $5.05 while adjusted EPS is estimated to be $6.75 to $6.90. CVS expects to achieve adjusted EPS of at least $7.00 in 2020, mid-single digit percent adjusted EPS growth in 2021, and low double digit percent growth in 2022 and beyond.